TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.

However, the sensitivity reported in our study is just barely significant ( p = 0.0495), perhaps explaining this discrepancy.

also in 26 other papers

In all cases, subclones were significantly less sensitive, as determined by a highly significant increase in IC50, but additional factors could have arisen during selections to promote resistance.

also in 132,142 other papers